Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Daar

Showing results (41-50 of 222) with videos related to

Pageof 23
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapyGraeme J Moyle, Eric S Daar, Joseph M Gertner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224sChris T Longenecker, Douglas Kitch, Paul E Sax, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|October 27, 2012
Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjectsRussell E Poland, Lev Gertsik, Joya T Favreau, et al.
The Journal of Infectious Diseases|October 6, 2005
Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progressionEric S Daar, Henry S Lynn, Sharyne M Donfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2012
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescentsSolveig Tenckhoff, Thorsten Kaiser, Fritz Bredeek, et al.
Open Forum Infectious Diseases|March 4, 2015
Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trialSamir K Gupta, Douglas Kitch, Camlin Tierney, et al.
Pharmacogenetics and Genomics|February 22, 2014
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202Daniel H Johnson, Charles Venuto, Marylyn D Ritchie, et al.
Journal of Virology|May 3, 2014
Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reductionJustin De La Cruz, Thomas Vollbrecht, Patricia Frohnen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2008
Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with menPamina M Gorbach, Lydia N Drumright, Marjan Javanbakht, et al.
Pharmacogenetics and Genomics|July 7, 2015
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202Valentine Wanga, Charles Venuto, Gene D Morse, et al.
Pageof 23

Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapyGraeme J Moyle, Eric S Daar, Joseph M Gertner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224sChris T Longenecker, Douglas Kitch, Paul E Sax, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|October 27, 2012
Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjectsRussell E Poland, Lev Gertsik, Joya T Favreau, et al.
The Journal of Infectious Diseases|October 6, 2005
Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progressionEric S Daar, Henry S Lynn, Sharyne M Donfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2012
Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescentsSolveig Tenckhoff, Thorsten Kaiser, Fritz Bredeek, et al.
Open Forum Infectious Diseases|March 4, 2015
Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trialSamir K Gupta, Douglas Kitch, Camlin Tierney, et al.
Pharmacogenetics and Genomics|February 22, 2014
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202Daniel H Johnson, Charles Venuto, Marylyn D Ritchie, et al.
Journal of Virology|May 3, 2014
Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reductionJustin De La Cruz, Thomas Vollbrecht, Patricia Frohnen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2008
Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with menPamina M Gorbach, Lydia N Drumright, Marjan Javanbakht, et al.
Pharmacogenetics and Genomics|July 7, 2015
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202Valentine Wanga, Charles Venuto, Gene D Morse, et al.
Pageof 23